Literature DB >> 18251164

Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.

Ken Shirabe1, Shigeki Wakiyama, Tomonobu Gion, Kenta Motomura, Toshimasa Koyanagi, Shigeru Sakamoto, Takashi Nagaie.   

Abstract

BACKGROUND/AIMS: The recurrence rate after hepatectomy of hepatocellular carcinoma (HCC) remains high. Although the cause of recurrence seems to be the multicentric occurrence and metastasis of cancer cells in the patients after curative resection of HCC, the mechanism of HCC recurrence in each case is still uncertain. The recurrence pattern may illuminate these mechanisms.
METHODOLOGY: A data analysis of 152 patients who underwent HCC resection, and had observed for more than 5 years was conducted. These patients were divided into three groups; group I (n=32), the patients without HCC recurrence, group II (n=86), the patients with fewer than four recurrent nodules of HCC, group III (n=34), the patients with four or more recurrent nodules of HCC. We compared the clinicopathological data of groups I and II, and of groups I and III. The linkage of risk factors linked to recurrence patterns was clarified.
RESULTS: The risk factors linked to group II by comparison with group I were high serum levels of alanine aminotransferase, low serum levels of albumin, high values in the indocyanine green retention test at fifteen minutes, hepatitis C antibody positivity. low platelet counts, and high histological hepatitis activity. The risk factors linked to group III were large tumor size, histological presence of portal vein invasion by cancer cells, intrahepatic metastasis, and poor differentiation of cancer cells.
CONCLUSIONS: The risk factors linked to recurrence with no more than three HCC nodules recurrence were related to host-related factors such as hepatic function, and hepatitis activity, but not tumor related. The risk factors linked to multiple recurrence were tumor related. The analysis of recurrence patterns revealed that completely different mechanisms exist in the patients with recurrence involving no more than four nodules, which may be related to multicentric occurrence, and patients with multiple recurrence, which may be related to the metastasis of cancer cells.

Entities:  

Mesh:

Year:  2007        PMID: 18251164

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era.

Authors:  Ken Shirabe; Kazuki Takeishi; Akinobu Taketomi; Hideaki Uchiyama; Hiroto Kayashima; Yoshihiko Maehara
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

2.  mPGES-1 expression in non-cancerous liver tissue impacts on postoperative recurrence of HCC.

Authors:  Koichi Nonaka; Hikaru Fujioka; Yasushi Takii; Seigo Abiru; Kiyoshi Migita; Masahiro Ito; Takashi Kanematsu; Hiromi Ishibashi
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

3.  Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion.

Authors:  Ken Shirabe; Kiyoshi Kajiyama; Norifumi Harimoto; Hideaki Masumoto; Tatsuro Fukuya; Masafumi Ooya; Yoshihiko Maehara
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

4.  A comparison of the risk factors of intrahepatic recurrence, early recurrencen, and multiple recurrences after resection for single nodular hepatocellular carcinoma.

Authors:  Hyun Joon An; Woo Young Shin; Keon-Young Lee; Seung-Ik Ahn
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2015-08-28

5.  Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).

Authors:  Chaohui Zuo; Man Xia; Qunfeng Wu; Haizhen Zhu; Jingshi Liu; Chen Liu
Journal:  Oncol Lett       Date:  2014-11-21       Impact factor: 2.967

6.  Downregulation of Heparanase Expression Results in Suppression of Invasion, Migration, and Adhesion Abilities of Hepatocellular Carcinoma Cells.

Authors:  Xiao-Peng Chen; Jun-Sheng Luo; Ye Tian; Chen-Lin Nie; Wei Cui; Wei-Dong Zhang
Journal:  Biomed Res Int       Date:  2015-12-29       Impact factor: 3.411

7.  Heparanase Contributes To Trans-Endothelial Migration of Hepatocellular Carcinoma Cells.

Authors:  Xiaopeng Chen; Wen Jiang; Chaofu Yue; Wenjun Zhang; Chaogang Tong; Dafei Dai; Bin Cheng; Chen Huang; Linming Lu
Journal:  J Cancer       Date:  2017-09-16       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.